Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Pulmonary Hypertension

  Free Subscription


Articles published in J Heart Lung Transplant

Retrieve available abstracts of 128 articles:
HTML format



Single Articles


    April 2024
  1. BUNCLARK K, Toshner M
    Anthropometrics are important to consider in purported sex differences in CTEPH outcomes.
    J Heart Lung Transplant. 2024;43:688.
    PubMed    


    February 2024
  2. ZEDER K, Marsh LM, Avian A, Brcic L, et al
    Compartment-specific remodeling patterns in end-stage chronic obstructive pulmonary disease with and without severe pulmonary hypertension.
    J Heart Lung Transplant. 2024 Feb 19:S1053-2498(24)01087.
    PubMed     Abstract available


  3. RAKO ZA, Yogeswaran A, Yildiz S, Weidemann P, et al
    Liver stiffness is associated with right heart dysfunction, cardiohepatic syndrome, and prognosis in pulmonary hypertension.
    J Heart Lung Transplant. 2024 Feb 17:S1053-2498(24)00056.
    PubMed     Abstract available


  4. DESJARDIN JT, Kime N, Kolaitis NA, Kronmal RA, et al
    Investigating the "sex paradox" in pulmonary arterial hypertension: results from the Pulmonary Hypertension Association Registry (PHAR).
    J Heart Lung Transplant. 2024 Feb 13:S1053-2498(24)00044.
    PubMed     Abstract available


  5. MCLAUGHLIN V, Farber HW, Highland KB, Hemnes AR, et al
    Disease characteristics, treatments, and outcomes of patients with pulmonary arterial hypertension treated with selexipag in real-world settings from the SPHERE registry (SelexiPag: tHe usErs dRug rEgistry).
    J Heart Lung Transplant. 2024;43:272-283.
    PubMed     Abstract available


  6. CHIA AXF, Valchanov K, Ng C, Tsui S, et al
    Perioperative extracorporeal membrane oxygenation support for pulmonary endarterectomy: A 17-year experience from the UK national cohort.
    J Heart Lung Transplant. 2024;43:241-250.
    PubMed     Abstract available


    January 2024
  7. GHIO S, Corsico A, Rapagnani A, Borrelli E, et al
    Does pulmonary endarterectomy improve the clinical conditions of patients with chronic thromboembolic pulmonary disease without pulmonary hypertension?
    J Heart Lung Transplant. 2024 Jan 4:S1053-2498(23)02203.
    PubMed     Abstract available


  8. JUTANT EM, Chelgham MK, Ottaviani M, Thuillet R, et al
    Central role of ubiquitin-specific protease 8 in leptin signaling pathway in pulmonary arterial hypertension.
    J Heart Lung Transplant. 2024;43:120-133.
    PubMed     Abstract available


    December 2023
  9. PARIKH R, Farber HW
    Response to "Derivation and validation of a noninvasive prediction tool to identify pulmonary hypertension in patients with IPF: Evolution of the model FORD" by Nathan et al.
    J Heart Lung Transplant. 2023 Dec 27:S1053-2498(23)02199.
    PubMed    


  10. JANOWSKI AM, Ravellette KS, Insel M, Garcia JG, et al
    Advanced Hemodynamic and Cluster Analysis for Identifying Novel RV function subphenotypes in Patients with Pulmonary Hypertension.
    J Heart Lung Transplant. 2023 Dec 21:S1053-2498(23)02178.
    PubMed     Abstract available


  11. CRUZ-UTRILLA A, Lopez-Gude MJ, Velazquez M, Ynsaurriaga FA, et al
    Comment on the article titled "Impact of sex on outcome after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension" published by J. Chan et al.
    J Heart Lung Transplant. 2023 Dec 21:S1053-2498(23)02177.
    PubMed    


  12. TAKANO R, Aoki T, Asano R, Ueda J, et al
    Recurrent Pulmonary Hypertension After Balloon Pulmonary Angioplasty for Inoperable Chronic Thromboembolic Pulmonary Hypertension.
    J Heart Lung Transplant. 2023 Dec 19:S1053-2498(23)02174.
    PubMed     Abstract available


    November 2023
  13. KIANZAD A, Baccelli A, Braams NJ, Andersen S, et al
    Long-term effects of pulmonary endarterectomy on pulmonary hemodynamics, cardiac function and exercise capacity in chronic thromboembolic pulmonary hypertension.
    J Heart Lung Transplant. 2023 Nov 22:S1053-2498(23)02130.
    PubMed     Abstract available


  14. NATHAN SD, Chandel A, Wang Y, Xu J, et al
    Derivation and validation of a non-invasive prediction tool to identify pulmonary hypertension in patients with IPF: evolution of the model FORD.
    J Heart Lung Transplant. 2023 Nov 16:S1053-2498(23)02123.
    PubMed     Abstract available


    October 2023
  15. UKITA R, Patel YJ, Kelly Wu W, Francois SA, et al
    Ambulatory Seven-Day Mechanical Circulatory Support in Sheep Model of Pulmonary Hypertension and Right Heart Failure.
    J Heart Lung Transplant. 2023 Oct 29:S1053-2498(23)02081.
    PubMed     Abstract available


    August 2023
  16. YE JR, Hu SY, Lin YH, Huang CH, et al
    Surgery for fibrosing mediastinitis with severe pulmonary hypertension due to pulmonary venous stenosis.
    J Heart Lung Transplant. 2023 Aug 25:S1053-2498(23)02002.
    PubMed     Abstract available


  17. PIENN M, Gertz RJ, Gerhardt F, Kroger JR, et al
    CT-derived Lung Vessel Morphology Correlates with Prognostic Markers in Pre-capillary Pulmonary Hypertension.
    J Heart Lung Transplant. 2023 Aug 22:S1053-2498(23)01973.
    PubMed     Abstract available


  18. FERNANDES TM, Kim NH, Kerr KM, Auger WR, et al
    Distal vessel pulmonary thromboendarterectomy: Results from a single institution.
    J Heart Lung Transplant. 2023;42:1112-1119.
    PubMed     Abstract available


  19. STOLFO D, Barbisan D, Ameri P, Lombardi CM, et al
    Performance of risk stratification scores and role of comorbidities in older vs younger patients with pulmonary arterial hypertension.
    J Heart Lung Transplant. 2023;42:1082-1092.
    PubMed     Abstract available


  20. ZHANG J, Kan J, Wei Y, Zhang C, et al
    Treatment effects of pulmonary artery denervation for pulmonary arterial hypertension stratified by REVEAL risk score: Results from PADN-CFDA trial.
    J Heart Lung Transplant. 2023;42:1140-1151.
    PubMed     Abstract available


    July 2023
  21. RAKO ZA, Yogeswaran A, Lakatos BK, Fabian A, et al
    Clinical and functional relevance of right ventricular contraction patterns in pulmonary hypertension.
    J Heart Lung Transplant. 2023 Jul 12:S1053-2498(23)01935.
    PubMed     Abstract available


  22. CHAN JCY, Man HSJ, Asghar UM, McRae K, et al
    Impact of sex on outcome after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension.
    J Heart Lung Transplant. 2023 Jul 6:S1053-2498(23)01897.
    PubMed     Abstract available


  23. XIE F, Quan R, Zhang G, Tian H, et al
    Characteristics, treatments and survival of pulmonary arterial hypertension associated with congenital heart disease in China: Insights from a national multicenter prospective registry.
    J Heart Lung Transplant. 2023;42:974-984.
    PubMed     Abstract available


    June 2023
  24. WIEDENROTH CB, Guth S
    Response to Huang et al. regarding "Riociguat and balloon pulmonary angioplasty improve prognosis in patients with inoperable chronic thromboembolic pulmonary hypertension".
    J Heart Lung Transplant. 2023 Jun 20:S1053-2498(23)01908.
    PubMed    


    May 2023
  25. ASHWIN REDDY S, Swietlik EM, Robertson L, Michael A, et al
    Natural History of Chronic Thromboembolic Pulmonary Disease with no or mild Pulmonary Hypertension.
    J Heart Lung Transplant. 2023 May 16:S1053-2498(23)01848.
    PubMed     Abstract available


    April 2023
  26. STRUEBER M
    TREATMENT STRATEGIES FOR END-STAGE PULMONARY HYPERTENSION.
    J Heart Lung Transplant. 2023 Apr 4:S1053-2498(23)01814.
    PubMed    


    March 2023
  27. HUANG Y, Zhang QZ, Lv SJ
    Comments and opinions regarding "Riociguat and balloon pulmonary angioplasty improve prognosis in patients with inoperable chronic thromboembolic pulmonary Hypertension".
    J Heart Lung Transplant. 2023 Mar 20:S1053-2498(23)01788.
    PubMed    


  28. HADINNAPOLA CM, Southwood M, Hernandez-Sanchez J, Bunclark K, et al
    Angiopoietin 2 and hsCRP are associated with pulmonary hemodynamics and long-term mortality respectively in CTEPH-Results from a prospective discovery and validation biomarker study.
    J Heart Lung Transplant. 2023;42:398-405.
    PubMed     Abstract available


  29. FROST AE, Zhao C, Farber HW, Benza R, et al
    Smoking history and pulmonary arterial hypertension: Demographics, onset, and outcomes.
    J Heart Lung Transplant. 2023;42:377-389.
    PubMed     Abstract available


    January 2023
  30. NISHIHARA T, Shimokawahara H, Ogawa A, Naito T, et al
    Comparison of the safety and efficacy of balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension patients with surgically accessible and inaccessible lesions.
    J Heart Lung Transplant. 2023 Jan 19:S1053-2498(23)00007.
    PubMed     Abstract available


  31. ROSENKRANZ S, Pausch C, Coghlan JG, Huscher D, et al
    Risk stratification and response to therapy in patients with pulmonary arterial hypertension and comorbidities: A COMPERA analysis.
    J Heart Lung Transplant. 2023;42:102-114.
    PubMed     Abstract available


  32. URIEL MH, Clerkin KJ, Takeda K, Naka Y, et al
    Bridging to transplant with HeartMate 3 left ventricular assist devices in the new heart organ allocation system: An individualized approach.
    J Heart Lung Transplant. 2023;42:124-133.
    PubMed     Abstract available


    December 2022
  33. GALLARDO-VARA E, Ntokou A, Dave JM, Jovin DG, et al
    Vascular pathobiology of pulmonary hypertension.
    J Heart Lung Transplant. 2022 Dec 21:S1053-2498(22)02256.
    PubMed     Abstract available


  34. RICHTER MJ, Fortuni F, Alenezi F, D'Alto M, et al
    Imaging the right atrium in pulmonary hypertension: A systematic review and meta-analysis.
    J Heart Lung Transplant. 2022 Dec 9:S1053-2498(22)02243.
    PubMed     Abstract available


  35. KRIECHBAUM SD, Birmes J, Wiedenroth CB, Adameit MSD, et al
    Exercise MR-proANP unmasks latent right heart failure in CTEPH.
    J Heart Lung Transplant. 2022;41:1819-1830.
    PubMed     Abstract available


  36. FAUVEL C, Raitiere O, Boucly A, De Groote P, et al
    Interest of TAPSE/sPAP ratio for noninvasive pulmonary arterial hypertension risk assessment.
    J Heart Lung Transplant. 2022;41:1761-1772.
    PubMed     Abstract available


  37. ZI-YANG Y, Hezhi L, Nanshan X, Yin Z, et al
    Model for screening adult congenital heart disease surgery eligibility with echocardiography parameters.
    J Heart Lung Transplant. 2022;41:1831-1838.
    PubMed     Abstract available


    November 2022
  38. HIRSCH K, Nolley S, Ralph DD, Zheng Y, et al
    Circulating markers of inflammation and angiogenesis and clinical outcomes across subtypes of pulmonary arterial hypertension.
    J Heart Lung Transplant. 2022;42:173-82.
    PubMed     Abstract available


  39. UKITA R, Stokes JW, Wu WK, Patel YJ, et al
    Large animal preclinical investigation into the optimal extracorporeal life support configuration for pulmonary hypertension and right ventricular failure.
    J Heart Lung Transplant. 2022 Nov 6:S1053-2498(22)02205.
    PubMed     Abstract available


  40. BENZA RL, Gomberg-Maitland M, Farber HW, Vizza CD, et al
    Contemporary risk scores predict clinical worsening in pulmonary arterial hypertension - An analysis of FREEDOM-EV.
    J Heart Lung Transplant. 2022;41:1572-1580.
    PubMed     Abstract available


    October 2022
  41. DAHIYA G, Kyvernitakis A, Elhamdani A, Begg A, et al
    Prognostic role of pulmonary hemodynamics before transcatheter aortic valve replacement among patients with severe aortic stenosis.
    J Heart Lung Transplant. 2022 Oct 9:S1053-2498(22)02167.
    PubMed     Abstract available


  42. WEATHERALD J, Iqbal H, Mielniczuk L, Syed AR, et al
    Priorities for pulmonary hypertension research: A James Lind Alliance priority setting partnership.
    J Heart Lung Transplant. 2022 Oct 3. pii: S1053-2498(22)02160.
    PubMed     Abstract available


    September 2022
  43. MCGLOTHLIN DP, Granton J, Klepetko W, Beghetti M, et al
    ISHLT consensus statement: Perioperative management of patients with pulmonary hypertension and right heart failure undergoing surgery.
    J Heart Lung Transplant. 2022;41:1135-1194.
    PubMed     Abstract available


    August 2022
  44. GARRY JD, Kolaitis NA, Kronmal R, Thenappan T, et al
    Anticoagulation in pulmonary arterial hypertension - association with mortality, healthcare utilization, and quality of life: The Pulmonary Hypertension Association Registry (PHAR).
    J Heart Lung Transplant. 2022 Aug 28. pii: S1053-2498(22)02085.
    PubMed     Abstract available


  45. WIEDENROTH CB, Rolf A, Steinhaus K, Adameit MSD, et al
    Riociguat and balloon pulmonary angioplasty improve prognosis in patients with inoperable chronic thromboembolic pulmonary Hypertension.
    J Heart Lung Transplant. 2022 Aug 23. pii: S1053-2498(22)02077.
    PubMed     Abstract available


  46. KIANZAD A, van Wezenbeek J, Celant LR, Oosterveer FPT, et al
    Idiopathic pulmonary arterial hypertension patients with a high H2FPEF-score: Insights from the Amsterdam UMC PAH-cohort.
    J Heart Lung Transplant. 2022;41:1075-1085.
    PubMed     Abstract available


  47. BONTA PI, Tramper J, Eberl S, Tepaske R, et al
    Endobronchial blocker use for massive, focal pulmonary hemorrhage during pulmonary endarterectomy for CTEPH.
    J Heart Lung Transplant. 2022;41:1130-1133.
    PubMed     Abstract available


    July 2022
  48. GULATI G, Grandin EW, DeNofrio D, Upshaw JN, et al
    Association between postoperative hemodynamic metrics of pulmonary hypertension and right ventricular dysfunction and clinical outcomes after left ventricular assist device implantation.
    J Heart Lung Transplant. 2022 Jul 23. pii: S1053-2498(22)02029.
    PubMed     Abstract available


  49. HALPERN SE, Wright MC, Madsen G, Chow B, et al
    Textbook outcome in lung transplantation: Planned venoarterial extracorporeal membrane oxygenation versus off-pump support for patients without pulmonary hypertension.
    J Heart Lung Transplant. 2022 Jul 21. pii: S1053-2498(22)02041.
    PubMed     Abstract available


  50. REDDY SA, Nethercott SL, Teh W, De Bie EM, et al
    Prevalence and clinical significance of conduction disease in patients with idiopathic pulmonary arterial hypertension.
    J Heart Lung Transplant. 2022;41:861-865.
    PubMed     Abstract available


  51. HOEPER MM, Pausch C, Olsson KM, Huscher D, et al
    Prognostic value of improvement endpoints in pulmonary arterial hypertension trials: A COMPERA analysis.
    J Heart Lung Transplant. 2022;41:971-981.
    PubMed     Abstract available


    June 2022
  52. VICAIRE H, Pavec JL, Mercier O, Montani D, et al
    Risk stratification in patients with pulmonary arterial hypertension at the time of listing for lung transplantation.
    J Heart Lung Transplant. 2022 Jun 6. pii: S1053-2498(22)01974.
    PubMed     Abstract available


  53. BADAGLIACCA R, Rischard F, Giudice FL, Howard L, et al
    Incremental value of cardiopulmonary exercise testing in intermediate-risk pulmonary arterial hypertension.
    J Heart Lung Transplant. 2022;41:780-790.
    PubMed     Abstract available


  54. ABDELNOUR-BERCHTOLD E, Donahoe L, McRae K, Asghar U, et al
    Central venoarterial extracorporeal membrane oxygenation as a bridge to recovery after pulmonary endarterectomy in patients with decompensated right heart failure.
    J Heart Lung Transplant. 2022;41:773-779.
    PubMed     Abstract available


  55. SUN QW, Sun Z
    Stem cell therapy for pulmonary arterial hypertension: An update.
    J Heart Lung Transplant. 2022;41:692-703.
    PubMed     Abstract available


    May 2022
  56. WIEDENROTH CB, Deissner H, Adameit MSD, Kriechbaum SD, et al
    Complications of balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension: Impact on the outcome.
    J Heart Lung Transplant. 2022 May 20. pii: S1053-2498(22)01944.
    PubMed     Abstract available


  57. WEATHERALD J, Thakrar MV, Varughese RA, Kularatne M, et al
    Upfront riociguat and ambrisentan combination therapy for newly diagnosed pulmonary arterial hypertension: A prospective open-label trial.
    J Heart Lung Transplant. 2022;41:563-567.
    PubMed     Abstract available


  58. GAIOTTO FA, Bacal F, Steffen SP, Marcondes-Braga FG, et al
    A modified heterotopic heart transplant technique to bridge patients with "fixed" pulmonary hypertension: A case report.
    J Heart Lung Transplant. 2022 May 1. pii: S1053-2498(22)01917.
    PubMed    


    April 2022
  59. VAN WEZENBEEK J, Groeneveldt JA, Llucia-Valldeperas A, van der Bruggen CE, et al
    Interplay of sex hormones and long-term right ventricular adaptation in a Dutch PAH-cohort.
    J Heart Lung Transplant. 2022;41:445-457.
    PubMed     Abstract available


    March 2022
  60. BENZA RL, Boucly A, Farber HW, Frost AE, et al
    Change in REVEAL Lite 2 risk score predicts outcomes in patients with pulmonary arterial hypertension in the PATENT study.
    J Heart Lung Transplant. 2022;41:411-420.
    PubMed     Abstract available


    February 2022
  61. HUMBERT M, Simonneau G, Pittrow D, Delcroix M, et al
    Oral anticoagulants (NOAC and VKA) in chronic thromboembolic pulmonary hypertension.
    J Heart Lung Transplant. 2022 Feb 11. pii: S1053-2498(22)01804.
    PubMed     Abstract available


    December 2021
  62. KREMER N, Rako Z, Douschan P, Gall H, et al
    Unmasking right ventricular-arterial uncoupling during fluid challenge in pulmonary hypertension.
    J Heart Lung Transplant. 2021 Dec 5. pii: S1053-2498(21)02616.
    PubMed     Abstract available


    November 2021
  63. YOGESWARAN A, Tello K, Lund J, Klose H, et al
    Risk assessment in pulmonary hypertension based on routinely measured laboratory parameters.
    J Heart Lung Transplant. 2021 Nov 5. pii: S1053-2498(21)02575.
    PubMed     Abstract available


    October 2021
  64. HANSMANN G, Diekmann F, Chouvarine P, Ius F, et al
    Full recovery of right ventricular systolic function in children undergoing bilateral lung transplantation for severe PAH.
    J Heart Lung Transplant. 2021 Oct 29. pii: S1053-2498(21)02568.
    PubMed     Abstract available


  65. ROSEN K, Raanani E, Kogan A, Kenet G, et al
    Chronic thromboembolic pulmonary hypertension in patients with antiphospholipid syndrome: Risk factors and management.
    J Heart Lung Transplant. 2021 Oct 28. pii: S1053-2498(21)02569.
    PubMed     Abstract available


  66. HUG KP, Gerry Coghlan J, Cannon J, Taboada D, et al
    Serial right heart catheter assessment between balloon pulmonary angioplasty sessions identify procedural factors that influence response to treatment.
    J Heart Lung Transplant. 2021;40:1223-1234.
    PubMed     Abstract available


    September 2021
  67. BLANQUEZ-NADAL M, Piliero N, Guillien A, Doutreleau S, et al
    Exercise hyperventilation and pulmonary gas exchange in chronic thromboembolic pulmonary hypertension: Effects of balloon pulmonary angioplasty.
    J Heart Lung Transplant. 2021 Sep 22. pii: S1053-2498(21)02504.
    PubMed     Abstract available


  68. BOGAERT J, Claessen G, Dresselaers T, Masci PG, et al
    Magnetic resonance relaxometry of the liver - a new imaging biomarker to assess right heart failure in pulmonary hypertension.
    J Heart Lung Transplant. 2021 Sep 16. pii: S1053-2498(21)02492.
    PubMed     Abstract available


    August 2021
  69. FURFARO D, Rosenzweig EB, Shah L, Robbins H, et al
    Lung transplantation disparities based on diagnosis for patients bridging to transplant on extracorporeal membrane oxygenation.
    J Heart Lung Transplant. 2021 Aug 25. pii: S1053-2498(21)02459.
    PubMed     Abstract available


  70. DE PERROT M, Gopalan D, Jenkins D, Lang IM, et al
    Evaluation and management of patients with chronic thromboembolic pulmonary hypertension - consensus statement from the ISHLT.
    J Heart Lung Transplant. 2021 Aug 3. pii: S1053-2498(21)02440.
    PubMed     Abstract available


    July 2021
  71. BENZA RL, Ghofrani HA, Grunig E, Hoeper MM, et al
    Effect of riociguat on right ventricular function in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
    J Heart Lung Transplant. 2021 Jul 10. pii: S1053-2498(21)02399.
    PubMed     Abstract available


  72. KHIRFAN G, Li M, Wang X, Dweik RA, et al
    Is pulmonary vascular resistance index better than pulmonary vascular resistance in predicting outcomes in pulmonary arterial hypertension?
    J Heart Lung Transplant. 2021;40:614-622.
    PubMed     Abstract available


    June 2021
  73. IRELAND CG, Damico RL, Kolb TM, Mathai SC, et al
    Exercise right ventricular ejection fraction predicts right ventricular contractile reserve.
    J Heart Lung Transplant. 2021;40:504-512.
    PubMed     Abstract available


  74. AIRHART S, Badie N, Doyle M, Correa-Jacque P, et al
    Assessing hemodynamic response to submaximal exercise in pulmonary arterial hypertension patients using an implantable hemodynamic monitor.
    J Heart Lung Transplant. 2021;40:430-434.
    PubMed     Abstract available


    May 2021
  75. DAURIAT G, Reynaud-Gaubert M, Cottin V, Lamia B, et al
    Severe pulmonary hypertension associated with chronic obstructive pulmonary disease: A prospective French multicenter cohort.
    J Heart Lung Transplant. 2021 May 11. pii: S1053-2498(21)02307.
    PubMed     Abstract available


  76. OLSSON KM, Kamp JC, Hoeper MM
    Pregnancy in PAH: Reality is changing.
    J Heart Lung Transplant. 2021;40:395-396.
    PubMed    


    April 2021
  77. ARTHUR ATAAM J, Mercier O, Lamrani L, Amsallem M, et al
    Retraction notice to ICAM-1 PROMOTES THE ABNORMAL ENDOTHELIAL CELL PHENOTYPE IN CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION.
    J Heart Lung Transplant. 2021;40:318.
    PubMed     Abstract available


  78. KIM NH, Hemnes AR, Chakinala MM, Highland KB, et al
    Patient and disease characteristics of the first 500 patients with pulmonary arterial hypertension treated with selexipag in real-world settings from SPHERE.
    J Heart Lung Transplant. 2021;40:279-288.
    PubMed     Abstract available


    March 2021
  79. JEROME LP, Severine F, Olaf M, Pauline P, et al
    Lung and heart-lung transplantation for children with PAH: Dramatic benefits from the implementation of a high-priority allocation program in France.
    J Heart Lung Transplant. 2021 Mar 26. pii: S1053-2498(21)02239.
    PubMed     Abstract available


  80. GIRGIS RE, Hoeper MM
    Pulmonary hypertension in fibrosing idiopathic interstitial pneumonia: Uncertainties, challenges and opportunities.
    J Heart Lung Transplant. 2021 Mar 5. pii: S1053-2498(21)02221.
    PubMed     Abstract available


  81. TOBITA K, Goda A, Nishida Y, Takeuchi K, et al
    Factors contributing to exercise capacity in chronic thromboembolic pulmonary hypertension with near-normal hemodynamics.
    J Heart Lung Transplant. 2021 Mar 5. pii: S1053-2498(21)02222.
    PubMed     Abstract available


  82. WESLEY MILKS M, Sahay S, Benza RL, Farber HW, et al
    Risk assessment in patients with pulmonary arterial hypertension in the era of COVID 19 pandemic and the telehealth revolution: State of the art review.
    J Heart Lung Transplant. 2021;40:172-182.
    PubMed     Abstract available


  83. KAMP JC, von Kaisenberg C, Greve S, Winter L, et al
    Pregnancy in pulmonary arterial hypertension: Midterm outcomes of mothers and offspring.
    J Heart Lung Transplant. 2021;40:229-233.
    PubMed    


    February 2021
  84. BRAAMS NJ, van Leeuwen JW, Vonk Noordegraaf A, Nossent EJ, et al
    Right ventricular adaptation to pressure-overload: Differences between chronic thromboembolic pulmonary hypertension and idiopathic pulmonary arterial hypertension.
    J Heart Lung Transplant. 2021 Feb 28. pii: S1053-2498(21)02216.
    PubMed     Abstract available


  85. NATHAN SD, Cottin V, Behr J, Hoeper MM, et al
    Impact of lung morphology on clinical outcomes with riociguat in patients with pulmonary hypertension and idiopathic interstitial pneumonia: A post hoc subgroup analysis of the RISE-IIP study.
    J Heart Lung Transplant. 2021 Feb 19. pii: S1053-2498(21)02178.
    PubMed     Abstract available


  86. HOEPER MM, Held M
    Response to Badagliacca et al: Multi-dimensional assessment and cluster analysis for idiopathic pulmonary arterial hypertension phenotyping.
    J Heart Lung Transplant. 2021;40:167-168.
    PubMed    


  87. BADAGLIACCA R, Papa S, Rischard F
    Multidimensional assessment and cluster analysis for idiopathic pulmonary arterial hypertension phenotyping.
    J Heart Lung Transplant. 2021;40:166-167.
    PubMed    


    November 2020
  88. BESHAY S, Sahay S
    Risk stratification in pulmonary hypertension associated with interstitial lung disease: The holy grail?
    J Heart Lung Transplant. 2020 Nov 27. pii: S1053-2498(20)31850.
    PubMed    


  89. JONE PN, Duchateau N, Pan Z, Ivy DD, et al
    Right ventricular area strain from 3-dimensional echocardiography: Mechanistic insight of right ventricular dysfunction in pediatric pulmonary hypertension.
    J Heart Lung Transplant. 2020 Nov 15. pii: S1053-2498(20)31831.
    PubMed     Abstract available


    October 2020
  90. PEREZ-VIZCAINO F
    Lung ACE2 and ADAM17 in pulmonary arterial hypertension: Implications for COVID-19?
    J Heart Lung Transplant. 2020;39:1167-1169.
    PubMed    


    August 2020
  91. RANGANATH NK, Smith DE, Kon ZN
    Awareness of bias in lung transplant registry analyses.
    J Heart Lung Transplant. 2020;39:850-851.
    PubMed    


    July 2020
  92. BADAGLIACCA R, Sciomer S, Petrosillo N
    Endothelin receptor antagonists for pulmonary arterial hypertension and COVID-19: Friend or foe?
    J Heart Lung Transplant. 2020;39:729-730.
    PubMed    


    June 2020
  93. YOGESWARAN A, Tello K, Faber M, Sommer N, et al
    Risk assessment in severe pulmonary hypertension due to interstitial lung disease.
    J Heart Lung Transplant. 2020 Jun 25. pii: S1053-2498(20)31615.
    PubMed     Abstract available


  94. ROAN JN, Hsu CH, Fang SY, Chiu MS, et al
    ProT-alpha gene transfer attenuates cardiopulmonary remedying and mortality in a flow-induced pulmonary hypertension rat model.
    J Heart Lung Transplant. 2020 Jun 6. pii: S1053-2498(20)31580.
    PubMed     Abstract available


    May 2020
  95. DESJARDIN JT, Kolaitis NA, Kime N, Kronmal RA, et al
    Age-related differences in hemodynamics and functional status in pulmonary arterial hypertension: Baseline results from the Pulmonary Hypertension Association Registry.
    J Heart Lung Transplant. 2020 May 16. pii: S1053-2498(20)31557.
    PubMed     Abstract available


  96. PRESTON IR, Burger CD, Bartolome S, Safdar Z, et al
    Ambrisentan in portopulmonary hypertension: A multicenter, open-label trial.
    J Heart Lung Transplant. 2020;39:464-472.
    PubMed     Abstract available


    April 2020
  97. DAS BB, Jadotte MM, Chan KC
    Use of selexipag in a child with pulmonary hypertension associated with sickle cell disease.
    J Heart Lung Transplant. 2020 Apr 29. pii: S1053-2498(20)31535.
    PubMed    


  98. KWON JM, Kim KH, Medina-Inojosa J, Jeon KH, et al
    Artificial intelligence for early prediction of pulmonary hypertension using electrocardiography.
    J Heart Lung Transplant. 2020 Apr 23. pii: S1053-2498(20)31516.
    PubMed     Abstract available


  99. CHOMETTE L, Caravita S, Dewachter C, Abramowicz M, et al
    Genetic Profiling of Combined Post-Capillary and Pre-Capillary Pulmonary Hypertension in Left Heart Diseases.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  100. ROTHAS J, Mahoney E
    Pulmonary Hypertension Support Group: A Year in Review.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  101. BULLOCK J, Chau P, Wood L, Bock MJ, et al
    Short-Term Outcomes of Infants and Children Receiving Selexipag for Pulmonary Hypertension.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  102. DJELLAL Y, Vachiery J, Dewachter C, Roussoulieres A, et al
    Role of a Prediction Score of Heart Failure with Left Ventricular Preserved Ejection Fraction in the Differential Diagnosis of Pulmonary Hypertension.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  103. ALBULUSHI A, Dhar K, Stoller D, Hyden M, et al
    The Effect of Exercise on Endothelin 1 Level in Patients with Pulmonary Hypertension.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  104. GOLTS EM, Aoki KC, Afshar K, Bigbee JM, et al
    Tricuspid Surgery and Pulmonary Thromboendarterectomy in Patients with Chronic Thromboembolic Pulmonary Hypertension.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  105. KULARATNE M, Weatherald J, Varughese R, Helmersen D, et al
    Validation of a Nurse Led Triage Algorithm for New Referrals in a Specialized Pulmonary Hypertension Clinic.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  106. BOULATE D, Pavec JL, Kriens M, Mussot S, et al
    Switching from Heart-Lung to Double Lung Transplantations in Patients with Pre-Capillary Pulmonary Hypertension: A Monocentric Experience.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  107. KEARNEY K, Bart N, Robson D, Muthiah K, et al
    Haemodynamic Response of Pulmonary Hypertension Secondary to Left Heart Disease with Continuous Flow Left Ventricular Assist Device Therapy (CF-LVADS): Post-Transplant Outcomes.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  108. DESJARDIN JT, Svetlichnaya Y, Kolaitis NA, Singer JP, et al
    Right Ventricular Outflow Tract Doppler Envelope Notching Predicts Pulmonary Hypertension and Outcomes in Lung Transplant Candidates.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  109. ARTHUR ATAAM J, Amsallem M, Contrepois K, Guihaire J, et al
    Targeted Angiogenesis Gene Expression Profiling of Patients with Chronic Thromboembolic Pulmonary Hypertension.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  110. BOTTA L, Murana G, Fiorentino M, Marianna B, et al
    Impact of Severe Pulmonary Hypertension on Right Heart Hemodynamics and Outcomes Following Cardiac Transplantation: A Single Center Experience.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  111. GABANIC A, Smith SA
    Pulmonary Hypertension Resolves Post Transplantation in Patients Treated with Milrinone or Dobutamine.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  112. VISHNEVSKY A, Pirlamarla P, Massey HT, Goldhammer J, et al
    Severe Pulmonary Hypertension in the Setting of Complex Structural Heart Disease.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  113. BENTLEY RF, Barker M, Esfandiari S, Wright SP, et al
    The Relationship between Pulmonary Artery Pulse Pressure and Pulmonary Artery Wedge Pressure during Exercise in Health and in Patients with Suspected Pulmonary Hypertension.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  114. BART NK, Ambati C, Kearney K, Scheuer S, et al
    Outcomes of Patients with Chronic Thromboembolic Pulmonary Hypertension Risk Stratified by a Dedicated Heart Team to Receive Pulmonary Endarectomy or Balloon Pulmonary Angiogiplasty.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  115. WANG W, Wilson C, Collum S, Bi W, et al
    Beta Adrenoceptor Ligands for the Treatment of Group 3 Pulmonary Hypertension and Cor Pulmonale: A Novel Therapeutic Target?
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  116. KWON J, Kim K
    Artificial Intelligence for Early Prediction of Pulmonary Hypertension Using Electrocardiography.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  117. KANWAR MK
    Biomarkers in pulmonary arterial hypertension: Moving closer toward precision medicine?
    J Heart Lung Transplant. 2020;39:287-288.
    PubMed    


  118. BADAGLIACCA R, Rischard F, Papa S, Kubba S, et al
    Clinical implications of idiopathic pulmonary arterial hypertension phenotypes defined by cluster analysis.
    J Heart Lung Transplant. 2020;39:310-320.
    PubMed     Abstract available


    March 2020
  119. NASIR BS, Hartwig MG
    Secondary Pulmonary Hypertension; getting down to the nuts and BOLT. Author's reply to Ranganath et al.
    J Heart Lung Transplant. 2020 Mar 5. pii: S1053-2498(20)31424.
    PubMed    


    February 2020
  120. RUOPP NF, Maron BA
    Pulmonary arterial hypertension in the modern era: The intersection of genotype and phenotype.
    J Heart Lung Transplant. 2020;39:113-114.
    PubMed    


  121. HIRAIDE T, Kataoka M, Suzuki H, Aimi Y, et al
    Poor outcomes in carriers of the RNF213 variant (p.Arg4810Lys) with pulmonary arterial hypertension.
    J Heart Lung Transplant. 2020;39:103-112.
    PubMed     Abstract available


    January 2020
  122. SHAH M, Saeed O, Shin J, Murthy S, et al
    Predicted heart mass-based size matching among recipients with moderate pulmonary hypertension: Outcomes and sex effect.
    J Heart Lung Transplant. 2020 Jan 31. pii: S1053-2498(20)31357.
    PubMed     Abstract available


    December 2019
  123. BRAAMS NJ, Ruigrok D, Schokker MGM, Padervinskiene L, et al
    Pulmonary vascular imaging characteristics after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension.
    J Heart Lung Transplant. 2019 Dec 5. pii: S1053-2498(19)31791.
    PubMed     Abstract available


    September 2019
  124. ROSENZWEIG EB, Gannon WD, Madahar P, Agerstrand C, et al
    Extracorporeal life support bridge for pulmonary hypertension: A high-volume single-center experience.
    J Heart Lung Transplant. 2019 Sep 12. pii: S1053-2498(19)31671.
    PubMed     Abstract available


    February 2019
  125. SHAFRAN I, Lang IM
    Diffusion capacity of the lung-a disease biomarker linking ventilation and circulation.
    J Heart Lung Transplant. 2019;38:130-132.
    PubMed    


  126. AIRHART S, Verlinden N, Badie N, Raina A, et al
    Use of an implantable wireless pulmonary pressure monitor during transition of therapy in pulmonary arterial hypertension.
    J Heart Lung Transplant. 2019;38:227-230.
    PubMed    


  127. VACHIERY JL, Galie N, Barbera JA, Frost AE, et al
    Initial combination therapy with ambrisentan+tadalafil on pulmonary arterial hypertensionrelated hospitalization in the AMBITION trial.
    J Heart Lung Transplant. 2019;38:194-202.
    PubMed     Abstract available


    January 2019
  128. FROST A, Janmohamed M, Fritz JS, McConnell JW, et al
    Safety and tolerability of transition from inhaled treprostinil to oral selexipag in pulmonary arterial hypertension: Results from the TRANSIT-1 study.
    J Heart Lung Transplant. 2019;38:43-50.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.